Subscribe to RSS
DOI: 10.1055/s-0040-1715856
Iron Deficiency Anemia and Serum Hepcidin Level in Children with Typhoid Fever: A Case–Control Study
Funding None.![](https://www.thieme-connect.de/media/10.1055-s-00029028/202006/lookinside/thumbnails/10-1055-s-0040-1715856_2000039-1.jpg)
Abstract
Objective Typhoid fever is a common systemic bacterial infection in children with a complex interplay between serum hepcidin and iron. We investigated the relationship between iron deficiency anemia (IDA) and serum hepcidin level in children with acute typhoid fever.
Methods We conducted a preliminary case–control study in Mansoura University Children's Hospital, Egypt from April 2017 to May 2019 including 30 children aged 5 to 15 years with confirmed acute typhoid fever. We recruited 15 healthy nonanemic children, of comparable ages and sex as controls from the same hospital while attending for nonfebrile complaints. Typhoid fever cases were subdivided according to IDA existence into 16 cases with IDA and 14 non-IDA cases. We excluded all children having diseases which may affect serum iron and hepcidin levels, for example, liver, blood, gastrointestinal, and kidney diseases, and patients receiving drugs interfering with iron metabolism. All participants were subjected to complete blood count, serum ferritin, iron, hepcidin levels, and total iron-binding capacity (TIBC).
Results In non-IDA typhoid fever group, serum iron level was significantly low, while serum hepcidin level was significantly high when compared with controls (p < 0.001 and p = 0.02, respectively). In IDA typhoid fever group, no statistically significant difference existed as regards serum hepcidin level when compared with controls (p = 0.53). No significant correlations were detected between serum hepcidin levels and hemoglobin, serum iron, ferritin, and TIBC values in each group.
Conclusion Preexisting iron status could affect serum hepcidin level in patients with acute typhoid fever. Coexistence of IDA might oppose the up-regulatory effect of acute typhoid fever on serum hepcidin level.
Publication History
Received: 21 March 2020
Accepted: 20 July 2020
Article published online:
04 September 2020
Georg Thieme Verlag KG
Stuttgart · New York
-
References
- 1 Buckle GC, Walker CLF, Black RE. Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2012; 2 (01) 010401
- 2 Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004; 82 (05) 346-353
- 3 Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 2002; 347 (22) 1770-1782
- 4 Strugnell RA, Scott TA, Wang N. et al. Salmonella vaccines: lessons from the mouse model or bad teaching?. Curr Opin Microbiol 2014; 17: 99-105
- 5 Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol 2009; 21 (01) 63-67
- 6 Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol 2012; 10 (08) 525-537
- 7 Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276 (11) 7806-7810
- 8 Liu J, Sun B, Yin H, Liu S. Hepcidin: a promising therapeutic target for iron disorders: a systematic review. Medicine (Baltimore) 2016; 95 (14) e3150
- 9 Nemeth E, Rivera S, Gabayan V. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113 (09) 1271-1276
- 10 Pietrangelo A, Dierssen U, Valli L. et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007; 132 (01) 294-300
- 11 Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007; 109 (01) 353-358
- 12 Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006; 108 (09) 3204-3209
- 13 Cassat JE, Skaar EP. Iron in infection and immunity. Cell Host Microbe 2013; 13 (05) 509-519
- 14 Nemeth E, Tuttle MS, Powelson J. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306 (5704): 2090-2093
- 15 Stefanova D, Raychev A, Arezes J. et al. Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood 2017; 130 (03) 245-257
- 16 Willemetz A, Beatty S, Richer E. et al. Iron- and hepcidin-independent downregulation of the iron exporter ferroportin in macrophages during Salmonella infection. Front Immunol 2017; 8: 498
- 17 Ganz T. Iron and infection. Int J Hematol 2018; 107 (01) 7-15
- 18 Nairz M, Schleicher U, Schroll A. et al. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med 2013; 210 (05) 855-873
- 19 Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 2001; 98 (15) 8160-8162
- 20 Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352 (10) 1011-1023
- 21 Ramos E, Kautz L, Rodriguez R. et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 2011; 53 (04) 1333-1341
- 22 Chlosta S, Fishman DS, Harrington L. et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica . Infect Immun 2006; 74 (05) 3065-3067
- 23 Darton TC, Blohmke CJ, Giannoulatou E. et al. Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans. PLoS Negl Trop Dis 2015; 9 (09) e0004029
- 24 Kim DK, Jeong JH, Lee JM. et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med 2014; 20 (04) 419-424
- 25 Özdemir N. Iron deficiency anemia from diagnosis to treatment in children. Turk Pediatri Ars 2015; 50 (01) 11-19
- 26 Habte L, Tadesse E, Ferede G, Amsalu A. Typhoid fever: clinical presentation and associated factors in febrile patients visiting Shashemene Referral Hospital, southern Ethiopia. BMC Res Notes 2018; 11 (01) 605
- 27 Upadhyay R, Nadka MY, Muruganathan A. et al. API recommendations for the management of typhoid fever. J Assoc Physicians India 2015; 63 (11) 77-96
- 28 Ohanu ME, Iroezindu MO, Maduakor U, Onodugo OD, Gugnani HC. Typhoid fever among febrile Nigerian patients: prevalence, diagnostic performance of the Widal test and antibiotic multi-drug resistance. Malawi Med J 2019; 31 (03) 184-192
- 29 Singh L, Cariappa MP. Blood culture isolates and antibiogram of Salmonella: experience of a tertiary care hospital. Med J Armed Forces India 2016; 72 (03) 281-284
- 30 White D, Kramer D, Johnson G, Dick F, Hamilton H. Estimation of serum ferritin by using enzyme immunoassay method. Am J Clin Pathol 1986; 72: 346-351
- 31 Manolov V, Atanasova B, Vasilev V, Tzatchev K, Velizarova M. ELISA method for serum hepcidin quantification in Bulgarian population. Acta Medica Bulgarica 2014; 41 (01) 22-29
- 32 Smith CL, Arvedson TL, Cooke KS. et al. IL-22 regulates iron availability in vivo through the induction of hepcidin. J Immunol 2013; 191 (04) 1845-1855
- 33 Jain S, Gautam V, Naseem S. Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 2011; 3 (01) 118-127
- 34 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39 (02) 175-191